Significance of mucin expression in pancreatobiliary neoplasms

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 2, 2010, Pages 108-124

  Yonezawa, Suguru ^a   Higashi, Michiyo ^a   Yamada, Norishige ^b   Yokoyama, Seiya ^a   Goto, Masamichi ^c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c National Sanatorium Hoshizuka Keiaien   (Japan)

Author keywords

Biliary neoplasm; Epigenetics; Immunohistochemistry; Mucin; Pancreatic neoplasm

Indexed keywords

HISTONE H3; MUCIN; MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN 7; DNA; MUC1 PROTEIN, HUMAN; MUC2 PROTEIN, HUMAN; MUC4 PROTEIN, HUMAN; MUC5AC PROTEIN, HUMAN; TUMOR MARKER;

BILE DUCT CARCINOMA; BILIARY TRACT INTRAEPITHELIAL NEOPLASIA; BILIARY TRACT TUMOR; DIAGNOSTIC VALUE; DNA METHYLATION; EARLY DIAGNOSIS; EPIGENETICS; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MUC1 GENE; MUC2 GENE; MUC4 GENE; MUC5AC GENE; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION; BILE DUCT TUMOR; BIOSYNTHESIS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PANCREAS; PATHOLOGY;

BILE DUCT NEOPLASMS; DISEASE PROGRESSION; DNA, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MUCIN 5AC; MUCIN-1; MUCIN-2; MUCIN-4; MUCINS; PANCREAS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77955819117     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0174-7     Document Type: Review

References (81)

1. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2:897-909. (Pubitemid 37328891)
2. Isaji S, Kawarada Y, Uemoto S. Classification of pancreatic cancer: Comparison of Japanese and UICC classifications. Pancreas. 2004;28:231-4. (Pubitemid 38437314)
3. Ishikawa O, Ohigashi H, Imaoka S, Nakaizumi A, Uehara H, Kitamura T, et al. Minute carcinoma of the pancreas measuring 1 cm or less in diameter-collective review of Japanese case reports. Hepatogastroenterology. 1999;46:8-15. (Pubitemid 29154713)
4. Egawa S, Takeda K, Fukuyama S, Motoi F, Sunamura M, Matsuno S. Clinicopathological aspects of small pancreatic cancer. Pancreas. 2004;28:235-40. (Pubitemid 38437315)
5. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000;127:498-505. (Pubitemid 30257507)
6. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525-31. (Pubitemid 35404319)
7. Wade TP, Prasad CN, Virgo KS, Johnson FE. Experience with distal bile duct cancers in US. Veterans affairs hospitals: 1987-1991. J Surg Oncol. 1997;64:242-5. (Pubitemid 27157415)
8. Fong Y, Blumgart LH, Lin E, Fortner JG, Brennan MF. Outcome of treatment for distal bile duct cancer. Br J Surg. 1996;83:1712-5. (Pubitemid 26421867)
9. Ouchi K, Matsuno S, Sato T. Long-term survival in carcinoma of the biliary tract. Analysis of prognostic factors in 146 resections. Arch Surg. 1989;124:248-52. (Pubitemid 19059754)
10. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system: 8 tumours of the liver and intrahepatic bile ducts, p. 157-99; 10 Tumours of the exocrine pancreas, p. 219-50. Lyon: IARC; 2000.
11. Shibahara H, Tamada S, Goto M, Oda K, Nagino M, Nagasaka T, et al. Pathologic features of mucin-producing bile duct tumors: Two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2004;28:327-38. (Pubitemid 38269566)
12. Zen Y, Fujii T, Itatsu K, Nakamura K, Minato H, Kasashima S, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333-43. (Pubitemid 44748384)
13. Takaori K. Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg. 2007;14:217-23. (Pubitemid 46863909)
14. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, et al. Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579-86. (Pubitemid 32423354)
15. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-87. (Pubitemid 38971421)
16. Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, et al. Biliary intraepithelial neoplasia: An international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007;20:701-9. (Pubitemid 46788877)
17. Hollingsworth MA, Swanson BJ. Mucins in cancer: Protection and control of the cell surfaces. Nat Rev Cancer. 2004;4:45-60. (Pubitemid 38082153)
18. Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int. 1997;47:813-30. (Pubitemid 28087380)
19. Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics. 2008;8:3329-41.
20. Lehmann JM, Riethmuller G, Johnson JP. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA. 1989;86:9891-5. (Pubitemid 20030740)
21. Chen Y, Zhao YH, Kalaslavadi TB, Hamati E, Nehrke K, Le AD, et al. Genome-wide search and identification of a novel gelforming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol. 2004;30:155-65. (Pubitemid 38147200)
22. Higuchi T, Orita T, Nakanishi S, Katsuya K, Watanabe H, Yamasaki Y, et al. Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem. 2004;279:1968-79. (Pubitemid 38084468)
23. Itoh Y, Kamata-Sakurai M, Denda-Nagai K, Nagai S, Tsuiji M, Ishii-Schrade K, et al. Identification and expression of human epiglycanin/MUC21: A novel transmembrane mucin. Glycobiology. 2008;18:74-83.
24. Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK. Structural organization and classification of the human mucin genes. Front Biosci. 2001;6:D1192-206.
25. Osako M, Yonezawa S, Siddiki B, Huang J, Ho JJ, Kim YS, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer. 1993;71:2191-9.
26. Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai K, et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer. 1993;55:82-91. (Pubitemid 23261711)
27. Kitamura H, Yonezawa S, Tanaka S, Kim YS, Sato E. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: Their relationship to prognosis. Jpn J Cancer Res. 1996;87:631-40. (Pubitemid 26235555)
28. Yonezawa S, Sueyoshi K, Nomoto M, Kitamura H, Nagata K, Arimura Y, et al. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: Its close relationship with prognosis of the patients. Hum Pathol. 1997;28:344-52. (Pubitemid 27106088)
29. Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, et al. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma. Hepatology. 1999;30:1347-55.
30. Yonezawa S, Nakamura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg. 2002;9:328-41. (Pubitemid 34993681)
31. Nakamura A, Horinouchi M, Goto M, Nagata K, Sakoda K, Takao S, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: Its relationship with potential for malignancy. J Pathol. 2002;197:201-10. (Pubitemid 34567608)
32. Horinouchi M, Nagata K, Nakamura A, Goto M, Takao S, Sakamoto M, et al. Expression of different glycoforms of membrane mucin (MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem Cytochem. 2003;36:443-53. (Pubitemid 37433062)
33. Tamada S, Goto M, Nomoto M, Nagata K, Shimizu T, Tanaka S, et al. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis. Pathol Int. 2002;52:713-23. (Pubitemid 35472026)
34. Yonezawa S, Higashi M, Yamada N, Goto M. Precursor lesions of pancreatic cancer. Gut and Liver. 2008;2:137-54.
35. Carraway KL, Ramsauer VP, Haq B, Carothers Carraway CA. Cell signaling through membrane mucins. Bioessays. 2003; 25:66-71. (Pubitemid 36093327)
36. Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, et al. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology. 2004;39:220-9. (Pubitemid 38461485)
37. Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T, et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol. 2005;58:845-52. (Pubitemid 41113392)
38. Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, Imai K, et al. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res. 2006;12:4257-64.
39. Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, et al. Mucins expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg. 2007;14:243-54. (Pubitemid 46863913)
40. Kim GE, Bae HI, Park HU, Kuan SF, Crawley SC, Ho JJ, et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology. 2002;123:1052-60.
41. Zen Y, Sasaki M, Fujii T, Chen TC, Chen MF, Yeh TS, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol. 2006;44:249-50.
42. Yamada N, Nishida Y, Tsutsumida H, Hamada T, Goto M, Higashi M, et al. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells. Cancer Res. 2008;68:2708-16. (Pubitemid 351556268)
43. Hamada T, Goto M, Tsutsumida H, Nomoto M, Higashi M, Sugai T, et al. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing. Cancer Lett. 2005;227:175-84. (Pubitemid 41169931)
44. Yamada N, Hamada T, Goto M, Tsutsumida H, Higashi M, Nomoto M, et al. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. Int J Cancer. 2006;119:1850-7. (Pubitemid 44356842)
45. Yamada N, Nishida Y, Tsutsumida H, Goto M, Higashi M, Nomoto M, et al. Promoter CpG methylation in cancer cells contributes to regulation of MUC4. Br J Cancer. 2009;100:344-51.
46. Yamada N, Yokoyama S, Nishida Y, Houjou I, Tsutsumida H, Goto M, et al. CpG methylation in the distal region of MUC5AC promoter contributes to the regulation of MUC5AC. Abstract in 68th annual meeting of the Japanese Cancer Society, Yokohama, 1-3 Oct 2009.
47. Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, et al. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol. 2002; 117:791-6. (Pubitemid 34457016)
48. Park HU, Kim JW, Kim GE, Bae HI, Crawley SC, Yang SC, et al. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia. Pancreas. 2003;26:e48-54.
49. Lüttges J, Zamboni G, Longnecker D, Klöppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001; 25:942-8. (Pubitemid 32594989)
50. Yonezawa S, Horinouchi M, Osako M, Kubo M, Takao S, Arimura Y, et al. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: Its relationship with the biological behavior of the tumor. Pathol Int. 1999;49:45-54. (Pubitemid 29421947)
51. Adsay NV, Merati K, Basturk O, Iacobuzio-Donahue C, Levi E, Cheng JD, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839-48. (Pubitemid 38856838)
52. Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study. Virchows Arch. 2005;447:794-9. (Pubitemid 41728866)
53. Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, et al. Mucin gene expression in intraductal papillarymucinous pancreatic tumours and related lesions. J Pathol. 2002;197:632-7.
54. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
55. Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-95.
56. Yonezawa S, Taira M, Osako M, Kubo M, Tanaka S, Sakoda K, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int. 1998;48:319-22. (Pubitemid 28328315)
57. Gum JR Jr. Mucin genes and the proteins they encode: Structure, diversity, and regulation. Am J Respir Cell Mol Biol. 1992; 7:557-64.
58. Gum JR Jr, Hicks JW, Toribara NW, Siddiki B, Kim YS. Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem. 1994; 269:2440-6.
59. Kim YS, Gum JR Jr. Diversity of mucin genes, structure, function, and expression. Gastroenterology. 1995;109:999-1001.
60. Pigny P, Guyonnet-Duperat V, Hill AS, Pratt WS, Galiegue-Zouitina S, d'Hooge MC, et al. Human mucin genes assigned to 11p15.5: Identification and organization of a cluster of genes. Genomics. 1996;38:340-52. (Pubitemid 27030123)
61. Buisine MP, Janin A, Maunoury V, Audié JP, Delescaut MP, Copin MC, et al. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology. 1996;110:84-91. (Pubitemid 26021607)
62. Lüttges J, Feyerabend B, Buchelt T, Pacena M, Klöppel G. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol. 2002;26:466-71. (Pubitemid 34280119)
63. Terada T, Ohta T, Sasaki M, Nakanuma Y, Kim YS. Expression of MUC apomucins in normal pancreas and pancreatic tumours. J Pathol. 1996;180:160-5. (Pubitemid 26370181)
64. Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, et al. Mucinous cystic tumors of the pancreas: Clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23:410-22. (Pubitemid 29160001)
65. Nagata K. Analysis of mucins and CD10 expression in pancreatic intraductal neoplasia (in Japanese, with English abstract). Kagoshimadaigaku Igakuzashi (Med J Kagoshima Univ). 2005;57:7-17.
66. Liver Cancer study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, the 5th edition, revised version. Tokyo: Kanehara; 2009.
67. Kim HJ, Kim MH, Lee SK, Yoo KS, Park ET, Lim BC, et al. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2002;32:389-93.
68. Klöppel G, Kosmahl M. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? J Hepatol. 2006;44:249-50. (Pubitemid 43069204)
69. Sasaki M, Nakanuma Y, Kim YS. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology. 1998;27:54-61. (Pubitemid 28041534)
70. Sakamoto E, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, et al. Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: Value of percutaneous transhepatic biliary drainage and cholangioscopy. World J Surg. 1999;23:1038-43. discussion 1043-4.
71. Sakamoto E, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, et al. Clinicopathological studies of mucin-producing cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 1997;4:157-62. (Pubitemid 127722672)
72. Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS. Intraductal papillary-mucinous neoplasms of the pancreas: An analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002;94:62-77. (Pubitemid 34049043)
73. Ringel J, Lohr M. The MUC gene family: Their role in diagnosis and early detection of pancreatic cancer. Mol Cancer. 2003;2:1-5.
74. Kim YS, Gum JR Jr, Crawley SC, Deng G, Ho JJ. Mucin gene and antigen expression in biliopancreatic carcinogenesis. Ann Oncol. 1999;10(Suppl 4):51-5.
75. Jalanko H, Kuusela P, Roberts P, Sipponen P, Haglund CA, Makela O. Comparison of a new tumour marker, CA19-9, with alphafetoprotein and carcinoembryonic antigen in the patients with upper gastrointestinal diseases. J Clin Pathol. 1984;37:218-22. (Pubitemid 14182690)
76. Kuusela P, Jalanko H, Roberts P, Sipponen P, Mecklin JP, Pitkänen R, et al. Comparison of CA19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer. 1984;49:135-9. (Pubitemid 14156131)
77. Ohuchida K, Mizumoto K, Yamada D, Fujii K, Ishikawa N, Konomi H, et al. Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer. Int J Cancer. 2006;118:405-11. (Pubitemid 41779080)
78. Matsuno YK, Saito T, Gotoh M, Narimatsu H, Kameyama A. Supported molecular matrix electrophoresis: A new tool for characterization of glycoproteins. Anal Chem. 2009;81:3816-23.
79. Siddiqui J, Abe M, Hayes D, Shani E, Yunis E, Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA. 1988;85:2320-23. (Pubitemid 24315883)
80. Shibahara F, Goto M, Nimura Y, Yonezawa S. Pathological features of mucin-producing bile duct tumors: Comparison with pancreatic intraductal papillary-mucinous neoplasms (in Japanese with English abstract). Gazou Shindan. 2006;26:595-602.
81. Shibahara F, Yonezawa S, Nimura Y. Mucin-producing bile duct tumors with comparison to pancreatic IPMN in expression of mucin protein (in Japanese). Tan to Sui. 2006;27:451-7.